Construction And Real Estate Tenders

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Dynamic Acquisition System 'Sad Odice 2'

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Formoterol Aclidinium Bromide, Atc R03al05 for the Period May 1St, 2023 - April 30Th, 2025

(2023-Dps-4) Insurance Services

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Dupilumab, Atc D11ah05 for the Period May 1St, 2023 - April 30Th, 2025

Contract and Supplier Management Solution

Completion Non-exkl. Am Discount Agreements According to § 130a Paragraph 8 Sgb V Iwe So-called Open-house Model for Ws Ibuprofen (atc Code According to Who: M01ae01), Dargeon

Completion Non-exkl. Pharmaceutical Discounts According to Section 130a (8) Sgb V Iwe So-called Open-house Model for the Ws Metoprolol/hct (official Atc Code: C07bb22)

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Ingredient Aclidinium Bromide, Atc R03bb05 for the Period May 1St, 2023 - April 30Th, 2025

Conclusion of a Non-Exclusive Discount Agreement According to § 130A Para. 8 Sgb V for the Active Substance Pimecrolimus, Atc D11ah02 for the Period May 1St, 2023 - April 30Th, 2025